MTNB icon

Matinas BioPharma

51 hedge funds and large institutions have $9.31M invested in Matinas BioPharma in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$202K
2 +$55.5K
3 +$33K
4
BlackRock
BlackRock
New York
+$14.3K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$7.32K

Top Sellers

1 -$215K
2 -$128K
3 -$118K
4
Millennium Management
Millennium Management
New York
-$69.8K
5
Jane Street
Jane Street
New York
-$27.2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.14M
2
$1.41M
3
$903K
4
$705K
5
$504K
6
$417K
7
$275K
8
$256K
9
$223K
10
$216K
11
$204K
12
$144K
13
$130K
14
$119K
15
$77K
16
$70.7K
17
$64.1K
18
$59.4K
19
$53K
20
$34K
21
$33K
22
$29K
23
$28.2K
24
$21.6K
25
$21.6K